Evidence map›Paper›PMID 21733850›Full record

ArticleThe Journal of biological chemistry2011

K-Cl cotransporter gene expression during human and murine erythroid differentiation.

Dao Pan, Theodosia A Kalfa, Daren Wang, Mary Risinger, Scott Crable, Anna Ottlinger, Sharat Chandra, David B Mount, Christian A Hübner, Robert S Franco and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. The K-Cl cotransporter-3 in the mammalian kidney.Current opinion in nephrology and hypertension · 2023
    Review
  4. Article
  5. Article
  6. Role of the cation-chloride-cotransporters in the circadian system.Asian journal of pharmaceutical sciences · 2021
    Review
  7. Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.International journal of molecular sciences · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. KJournal of hematology & oncology · 2019
    Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Dao PanMolecular and Cell Therapy Program, Division of Experimental Hematology, Cincinnati, Ohio 45229; the Departments of Pediatrics, Cincinnati, Ohio 45267. Electronic address: dao.pan@cchmc.org.
Theodosia A Kalfathe Departments of Pediatrics, Cincinnati, Ohio 45267; Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229.
Daren WangMolecular and Cell Therapy Program, Division of Experimental Hematology, Cincinnati, Ohio 45229.
Mary RisingerDivision of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229.
Scott CrableDivision of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229.
Anna OttlingerDivision of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229.
Sharat Chandrathe Departments of Pediatrics, Cincinnati, Ohio 45267; Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229.
David B MountRenal Division, Brigham and Women's Hospital, Veterans Affairs Boston Healthcare System, Harvard Medical School, Boston, Massachusetts 02115.
Christian A HübnerDepartment of Clinical Chemistry, University Hospital of the Friedrich-Schiller-University, D-07747 Jena, Germany.
Robert S FrancoDivision of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229; Internal Medicine, University of Cincinnati School of Medicine, Cincinnati, Ohio 45267.
Clinton H Joinerthe Departments of Pediatrics, Cincinnati, Ohio 45267; Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229. Electronic address: clinton.joiner@cchmc.org.
Cincinnati Children's Hospital Medical Center · USBrigham and Women's Hospital · USFriedrich Schiller University Jena · DEUniversity of Cincinnati · US

Funding

Translational project: Gene therapy for Sickle Cell DiseaseU54HL070871 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI PARTIN-WELCH, POLLY · 2003 to 2011
$16.4M
MOLECULAR PHYSIOLOGY OF RENAL K+/ CL- COTRANSPORTERSR01DK057708 · NIDDK · VANDERBILT UNIVERSITY · PI MOUNT, DAVID BRUCE · 2000 to 2007
$2.1M
Genetic Therapy for CNS Manifestations in MPS I via BBB-targeted Protein DeliveryR01NS064330 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI PAN, DAO · 2008 to 2012
$1.6M
NHLBI NIH HHS HL070871NHLBI NIH HHS U54 HL070871NIDDK NIH HHS DK57708NIDDK NIH HHS R01 DK057708NINDS NIH HHS NS064330NINDS NIH HHS R01 NS064330
6 · The paper itself

Abstract

The K-Cl cotransporter (KCC) regulates red blood cell (RBC) volume, especially in reticulocytes. Western blot analysis of RBC membranes revealed KCC1, KCC3, and KCC4 proteins in mouse and human cells, with higher levels in reticulocytes. KCC content was higher in sickle versus normal RBC, but the correlation with reticulocyte count was poor, with inter-individual variability in KCC isoform ratios. Messenger RNA for each isoform was measured by real time RT-quantitative PCR. In human reticulocytes, KCC3a mRNA levels were consistently the highest, 1-7-fold higher than KCC4, the second most abundant species. Message levels for KCC1 and KCC3b were low. The ratios of KCC RNA levels varied among individuals but were similar in sickle and normal RBC. During in vivo maturation of human erythroblasts, KCC3a RNA was expressed consistently, whereas KCC1 and KCC3b levels declined, and KCC4 message first increased and then decreased. In mouse erythroblasts, a similar pattern for KCC3 and KCC1 expression during in vivo differentiation was observed, with low KCC4 RNA throughout despite the presence of KCC4 protein in mature RBC. During differentiation of mouse erythroleukemia cells, protein levels of KCCs paralleled increasing mRNA levels. Functional properties of KCCs expressed in HEK293 cells were similar to each other and to those in human RBC. However, the anion dependence of KCC in RBC resembled most closely that of KCC3. The results suggest that KCC3 is the dominant isoform in erythrocytes, with variable expression of KCC1 and KCC4 among individuals that could result in modulation of KCC activity.

Indexed as

Anemia, Sickle CellAnimalsAnionsCell DifferentiationCell Line, TumorChloridesErythrocytesGene Expression ProfilingHumansK Cl- CotransportersMiceReticulocytesSymportersAnionsChloridesK Cl- CotransportersSLC12A6 protein, humanSlc12a6 protein, mouseSLC12A7 protein, humanSlc12a7 protein, mouseSymporters

Identifiers

PMID21733850
PMCPMC3162409
OpenAlexW2052006029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.